NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study. - Nakai S; Makino T; Momose K; Yamashita K; Tanaka K; Miyata H; Yamamoto S; Motoori M; Kimura Y; Takeoka T; Hirao M; Matsuyama J; et al. (Cancer immunology, immunotherapy : CII, 2026)